Upsher-Smith Completes USL255 Phase III Clinical Trial in Patients With …

Published May 29, 2013

Upsher-Smith completes USL255 Phase III clinical trial in patients with …

Filed under: drug treatment programs washington dc

USL255 is specifically engineered to provide convenient once-daily dosing and reduce fluctuations in topiramate blood levels observed with currently available treatment options. Upsher-Smith's New Drug Application for USL255 has been accepted for …
Read more on News-Medical.net

New drug approved for advanced prostate cancer treatment

Filed under: drug treatment programs washington dc

A Washington, D.C., reporter for more than 30 years, Jim Limbach covers the federal agencies for ConsumerAffairs. … Men whose prostate cancer has spread after receiving medical or surgical therapy to lower testosterone have a new option for treatment …
Read more on ConsumerAffairs